In the journey of commercializing a technology, a big part of the task is clearing the hurdles along the way. There can be hurdles and potential hazards from the discovery and development of a technology to the testing, manufacturing and marketing. The NIH National Center for Advancing Translational Sciences (NCATS) tackles early-stage challenges, which can be some of the biggest in healthcare: making drug discovery and development faster, more efficient, and accessible for rare diseases.

Krishna (Balki) Balakrishnan, the director of NCATS’ Office of Strategic Alliances, and Ami Gadhia, a senior technology transfer and patenting specialist at NCATS' Office of Strategic Alliances, join the The Tech Transfer Files' podcast to talk about how NCATS breaks down the barriers that stand in the way of drug discovery and development from pioneering the use of human organoids to creating innovative collaboration models with external researchers. You’ll hear real-world examples of success, like the development of Metarrestin, a promising cancer treatment, and a partnership with Cincinnati Children’s that’s driving advancements in therapies for rare blood disorders.

If you’ve ever wondered how federal labs work to bring life-changing technologies to market or what it takes to accelerate the path from research to real-world impact, this episode is for you. Get ready to be inspired by the people, the mission, and the progress shaping the future of medicine. You can hear and share more Transfer Files conversations on the FLC website, YouTube, Apple, Spotify and other popular podcast platforms.

If you are interested in licensing from or collaborating with NCATS, please view the available technologies from NCATS.